Home

Smiling pharmacy student at white coat ceremony


Texas Pharmacy strives to be the leading institution for innovative interdisciplinary education, research and service to revolutionize patient care and health outcomes.

Apply now

Programs - College of Pharmacy faculty and student preparing vaccines


The college offers highly-ranked Pharm.D. and graduate programs, post-graduate residencies, postdoctoral training and continuing education. 

Explore our programs

Research and Practice - photo of researcher in lab


We are internationally recognized for groundbreaking research among the highest quality in the nation, with research funding over $20 million.

Learn about our research

Continuing Education - photo of pharmacy building sign


Continuing Pharmacy Education (CPE) meets the life-long professional development and practice needs of a variety of pharmacy audiences.

View our CPE offerings

#6

Best Pharmacy School

U.S. News & World Report

442

Pharm.D. Students

Total Enrollment

92%

Residency Match Rate

ASHP, 2024

118

Ph.D. and MS Students

Total Enrollment

#3

Non-Federal Research Funding

AACP, 2021-2022

#13

Total Research Grant Funding

AACP, 2021-2022

The University of Texas at Austin College of Pharmacy was founded in 1893 and is one of the top pharmacy schools in the nation.  The college's mission is to provide exemplary education, training, research, and professional development for Pharm.D. students, graduate students and postgraduates in the pharmaceutical sciences; to advance discovery, innovation, and patient care; and to provide service to the university, professional and scientific communities, and society.

 

Current College News

Introducing the Division of Pharmacotherapy and Translational Sciences (PTSCI) at UT Austin Pharmacy

A group of people posing in white coats and giving the Hook 'em Horns hand gesture in front of the UT Austin College of Pharmacy wordmark.
Aug. 8, 2024
The University of Texas at Austin College of Pharmacy’s Division of Pharmacotherapy in San Antonio is undergoing a significant transformation. Effective September 1, 2024, the group will become the Division of Pharmacotherapy and Translational Sciences (PTSCI) to better reflect its tremendous growth, expansion and strategic collaborations over the past decade. The PTSCI Division will pursue its mission to educate and train the future leaders of pharmacotherapy and translational science, engage in innovative research and provide exemplary patient care.

Vasquez Publishes Study in Nature Communications

A double helix of DNA with hotspots.
Aug. 7, 2024
Division Head and Professor of Pharmacology & Toxicology and Doluisio Regents Professor Karen Vasquez, Ph.D. recently published an article in Nature Communications. The study, titled “Obesity increases genomic instability at DNA repeat-mediated endogenous mutation hotspots,” represents the first demonstration that obesity increases genetic instability at alternative DNA structures (in this case H-DNA), which are hotspots for mutations in human cancers.

UT College of Pharmacy Program is Looking to Expand Patient Access

A tall clock tower with trees enveloping it in the foreground.
July 26, 2024
The Daily Texan recently spoke with UTCOP's Dean Samuel Poloyac and members of the pharmacy community about the development of Texas PharmCare, a collaborative program which will help combat barriers and allow pharmacists to easily access medical information necessary to assist patients with obtaining needed medication treatment.

UT Austin Neighborhood Pharmacy Program Working to Expand Patient Access

Two hands, one of them holding a prescription medication bottle full of capsules..
July 15, 2024
KXAN recently reported on the College of Pharmacy's Texas PharmCare program, which works to minimize barriers limiting pharmacists from accessing medication data and medical records from hospitals and clinics to better provide care for patients, partnering with Tarrytown Pharmacy, H-E-B and Watershed Health.

Manganese-Induced Parkinsonism Research Provides Potential Treatment Option

Dr. Mukhopadhyay wearing a collared shirt and smiling.
June 28, 2024
In a recent article in the Proceedings of the National Academy of Sciences (PNAS), ongoing research into the causes of manganese-induced parkinsonism has revealed a possible treatment option. Dr. Somshuvra Mukhopadhyay and a team of researchers have released new findings that the PHD2 inhibitor, which is the cell’s master oxygen sensor, has a second physiologically essential function – to also act as the cell’s manganese sensor.

Ginsburg Accepts Whitney Award at ASHP Pharmacy Futures 2024

Diane Ginsburg wearing pearls and smiling while standing in front of a tree and building.
June 19, 2024
Associate Dean for Healthcare Partnerships Dr. Diane Ginsburg received the Harvey A.K. Whitney Lecture Award at ASHP's Pharmacy Futures meeting last week. The award is health-system pharmacy’s highest honor.

Faculty and Students to be Recognized at 2024 TPA Conference & Expo

A green, white and black text logo for the Texas Pharmacy Foundation. It reads: "Texas Pharmacy Foundation. Funding The Future"
June 5, 2024
This July, UT Austin College of Pharmacy faculty and students will be recognized and presented with their awards at the 2024 TPA Conference & Expo in Allen, Texas.

Featured Open Positions

Ambulatory Care Clinical Faculty Member (Open Rank - Professional Track)

View full details and apply